“Our subsidiary, NuGenerex Diagnostics, has been developing a rapid, point-of-care diagnostics test for #infectiousdiseases including syphilis, HIV, tuberculosis-XT, hepatitis B & C, and malaria to be used by the #WorldHealthOrganization mainly in Africa.”
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links